ConductScience.org, home

Paper89390

Tolfenamic acid is as effective as ergotamine during migraine attacks.

Hakkarainen H and 3 others. Lancet, 1979. Cited by 112 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tolfenamic acid is as effective as ergotamine during migraine attacks. Papers, record 89390. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/89390

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tolfenamic acid is as effective as ergotamine during migraine attacks.
PubMed
Journal
Lancet
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
4.63
iCite
Revised in PubMed
2019-12-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hakkarainen HH
2Vapaatalo HH
3Gothoni GG
4Parantainen JJ

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErgotamineMajor topic
Migraine DisordersMajor topic
Prostaglandin AntagonistsMajor topic
ortho-AminobenzoatesMajor topic
Adolescent
Adult
Aspirin
Chemical Phenomena
Chemistry
Clinical Trials as Topic
Consumer Behavior
Double-Blind Method
Drug Evaluation
Female
Humans
Middle Aged
Nausea
Placebos
Vasoconstrictor Agents

Source PubMed

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
42,892,221Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats.J Physiol Sci2026https://conductscience.org/library/papers/42892221PubMed
40,903,946Prostaglandins: Key players in immunomodulation of the nervous system.Neural Regen Res2026https://conductscience.org/library/papers/40903946PubMed
38,157,876The history and rationale of the development of new drugs for migraine treatment.Arq Neuropsiquiatr2023https://conductscience.org/library/papers/38157876PubMed
28,878,750Identification of the Tolfenamic Acid Binding Pocket in PrbP from Liberibacter asiaticus.Front Microbiol2017https://conductscience.org/library/papers/28878750PubMed
28,421,555Pharmacological Agents Affecting Emesis : A Review (Part II).Drugs1992https://conductscience.org/library/papers/28421555PubMed
27,713,337NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713337PubMed
27,706,811Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.Int J Cancer2017https://conductscience.org/library/papers/27706811PubMed
24,462,621Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.Neuropharmacology2014https://conductscience.org/library/papers/24462621PubMed
20,086,170Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.Cancer Res2010https://conductscience.org/library/papers/20086170PubMed
15,222,892Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.BMC Neurol2004https://conductscience.org/library/papers/15222892PubMed
12,027,785Practical approaches to migraine management.CNS Drugs2002https://conductscience.org/library/papers/12027785PubMed
8,983,935Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose.Eur J Drug Metab Pharmacokinet1995https://conductscience.org/library/papers/8983935PubMed
8,838,783A review of the treatment of primary headaches. Part I: Migraine.Ital J Neurol Sci1995https://conductscience.org/library/papers/8838783PubMed
7,238,564Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7238564PubMed
7,166,179Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/7166179PubMed
6,991,241Migraine: current approach to prevention and treatment.Drugs1980https://conductscience.org/library/papers/6991241PubMed
6,691,890Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6691890PubMed
6,419,759Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6419759PubMed
3,899,452Clinical pharmacokinetics of ergotamine in migraine and cluster headache.Clin Pharmacokinet1985https://conductscience.org/library/papers/3899452PubMed
3,876,221Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3876221PubMed

See all 24 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/89390

GET https://conductscience.org/api/papers/v1/89390/cited_by?page=2